News & Insights

Acorn Regulatory ISO 9001 2015

Changes to ISO 9001

At Acorn Regulatory we are committed to ensuring quality in all aspects of what we do so it’s vital to… Read more

Acorn Regulatory - Industry Bodies Come Together To Host BioPharma Ambition Conference in Dublin

Industry Bodies Come Together To Host BioPharma Ambition.

Minister Simon Harris’ confirmation that the Irish government will soon be making a bid to be the new home of… Read more

acorn regulatory affairs newsletter

Acorn Regulatory Monthly Newsletter: September 2016

We have just launched our new Acorn Regulatory monthly newsletter.  You can read all of the stories from the newsletter… Read more

Implications of Brexit

The Implications of Brexit for the Life Sciences Sector

The implications of Brexit are still being felt.  Politically, the decision has triggered a chain of events that none of us… Read more

USA Canada align submission gateways regulatory applications regulatory submissions

Get The Industry News Roundup for September

In this month’s roundup of industry news roundup, we will be looking at how the USA and Canada are working… Read more

Acorn Regulatory work on site with our client in the south east of Ireland

Work On-Site With Our Client in the South-East of Ireland

Right now, we are seeking a consultant to work on-site with our client in the south-east of Ireland. The client is… Read more

Moving EU Authorised Representative Authorised Representatives BRexit Acorn Regul;atory Brexit Medical Device

Implications of Brexit for the Medical Device Sector

In this extract from our first Brexit whitepaper, written in July 2016, we look at the implications of Brexit for… Read more


EMA Introduces New Chapter on Good Pharmacovigilance Practices (EU-GVP)

The European Medicines Agency has added a new chapter (Product- or population-specific considerations II: Biological medicinal products) to its guidelines… Read more

Life Sciences Brexit

Brexit Clinical Trials Sector Implications

In this extract from our first Brexit whitepaper we look at the implications of Brexit for the clinical trials sector.

monthly Brexit newsletter

Brexit: The Implications on Existing Marketing Authorisations

In this extract from our first Brexit whitepaper we look at the implications of Brexit for existing marketing authorisations.

MHRA & Common European Submissions Portal

MHRA Moving Towards Paperless Communications

Following discussions with industry bodies, the MHRA is now replacing all paper-based communications with emails.  The emails will replace paper-based communications… Read more

Acorn Regulatory FDA to Offer Decrease in Medical Device Fees

Industry News Roundup: August

We are looking at five of the biggest stories in the pharmaceutical, medical devices and clinical trials sectors in the… Read more

Contact us and enjoy a faster, smoother journey through the maze of European Pharmaceutical and Medical Device legislation with us as your expert guide.
©2020 Acorn Regulatory Consultancy Services Ltd. Company Registration No. 397294 VAT Registered No. IE 6417294V
Designed by